108 related items for PubMed ID: 10950233
1. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A.
Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233
[Abstract] [Full Text] [Related]
2. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis.
Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R.
BMJ; 2001 Aug 04; 323(7307):253-6. PubMed ID: 11485952
[Abstract] [Full Text] [Related]
3. Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids.
Daley-Yates PT, Aggarwal B, Plank M.
Adv Ther; 2024 May 04; 41(5):1995-2009. PubMed ID: 38532238
[Abstract] [Full Text] [Related]
4. Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.
Mortimer KJ, Tattersfield AE, Tang Y, Wu K, Lewis S, Hochhaus G, Harrison TW.
Br J Clin Pharmacol; 2007 Oct 04; 64(4):439-44. PubMed ID: 17711540
[Abstract] [Full Text] [Related]
5. Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.
Mortimer KJ, Harrison TW, Tang Y, Wu K, Lewis S, Sahasranaman S, Hochhaus G, Tattersfield AE.
Br J Clin Pharmacol; 2006 Oct 04; 62(4):412-9. PubMed ID: 16995862
[Abstract] [Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects.
Allen A, Bal J, Cheesbrough A, Hamilton M, Kempsford R.
Br J Clin Pharmacol; 2014 May 04; 77(5):808-20. PubMed ID: 24152086
[Abstract] [Full Text] [Related]
7. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.
Drake AJ, Howells RJ, Shield JP, Prendiville A, Ward PS, Crowne EC.
BMJ; 2002 May 04; 324(7345):1081-2. PubMed ID: 11991916
[No Abstract] [Full Text] [Related]
8. Fluticasone propionate-induced regulation of the balance within macrophage subpopulations.
Tormey VJ, Bernard S, Ivory K, Burke CM, Poulter LW.
Clin Exp Immunol; 2000 Jan 04; 119(1):4-10. PubMed ID: 10606958
[Abstract] [Full Text] [Related]
9. Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics.
Drescher SK, Jiao Y, Chen MJ, Kurumaddali A, Shao J, Amini E, Hochhaus G, Bulitta JB.
Pharm Res; 2023 May 04; 40(5):1177-1191. PubMed ID: 37081302
[Abstract] [Full Text] [Related]
10. Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent.
Cass L, Murray A, Davis A, Woodward K, Albayaty M, Ito K, Strong P, Ayrton J, Brindley C, Prosser J, Murray J, French E, Haywood P, Wallis C, Rapeport G.
Pharmacol Res Perspect; 2021 Feb 04; 9(1):e00690. PubMed ID: 33340279
[Abstract] [Full Text] [Related]
11. Effects of inhaled fluticasone propionate on extrinsic tongue muscles in rats.
Setzke C, Broytman O, Russell JA, Morel N, Sonsalla M, Lamming DW, Connor NP, Teodorescu M.
J Appl Physiol (1985); 2020 Mar 01; 128(3):576-585. PubMed ID: 31944881
[Abstract] [Full Text] [Related]
12. A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment.
Zhang M, Si SJ, Dai WJ, Yang J, Wang Y, Wei XR, Liu S, Xu CY, Zhang C, Jin F, Jiang LQ.
Colloids Surf B Biointerfaces; 2023 Aug 01; 228():113364. PubMed ID: 37290201
[Abstract] [Full Text] [Related]
13. Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?
Newman SP.
Br J Clin Pharmacol; 2000 Jun 01; 49(6):529-37. PubMed ID: 10848716
[Abstract] [Full Text] [Related]
14. Effects of Inhaled Fluticasone Propionate on Wound Healing After Surgical Phonotrauma Model in Rabbit Larynx.
Aslıer M, İnan HC, Sarıçetin A, Coskun HH.
J Voice; 2023 Dec 07. PubMed ID: 38065809
[Abstract] [Full Text] [Related]
15. The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?
Whitlock GG, Patel A, Edwards SG, Benn PD, Miller RF.
Clin Med (Lond); 2012 Jun 07; 12(3):300-1. PubMed ID: 22783792
[No Abstract] [Full Text] [Related]
16. Severe bronchospasm induced by inhaled fluticasone propionate: A rare case report.
Li T, Yu Q, Liu Y.
Asian J Surg; 2024 Jun 03. PubMed ID: 38834455
[No Abstract] [Full Text] [Related]
17.
; 2006 Jun 03. PubMed ID: 29999836
[Abstract] [Full Text] [Related]
18. Degradation rates and products of fluticasone propionate in alkaline solutions.
Tokumura T, Yoshida N, Mori-Yasumoto K, Shirota O, Kurita T.
J Pharm Anal; 2017 Oct 03; 7(5):297-302. PubMed ID: 29404052
[Abstract] [Full Text] [Related]
19. iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes.
Bäckman P, Cabal A, Clark A, Ehrhardt C, Forbes B, Hastedt J, Hickey A, Hochhaus G, Jiang W, Kassinos S, Kuehl PJ, Prime D, Son YJ, Teague SP, Tehler U, Wylie J.
Mol Pharm; 2022 Jul 04; 19(7):2040-2047. PubMed ID: 35609877
[Abstract] [Full Text] [Related]
20. Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD.
Miravitlles M, Auladell-Rispau A, Monteagudo M, Vázquez-Niebla JC, Mohammed J, Nuñez A, Urrútia G.
Eur Respir Rev; 2021 Jun 30; 30(160):. PubMed ID: 34168063
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
